ArticleAmerican journal of cancer research2015

Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study.

Wenlei Zhuo et al.PubMed ↗Full text ↗

No numbers read from the abstract.